Assenagon Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-379
| Closed | -$4.21K | – | 1428 |
|
|
2024
Q3 | $4.21K | Sell |
379
-20
| -5% | -$222 | ﹤0.01% | 1316 |
|
|
2024
Q2 | $3.7K | Sell |
399
-4,416
| -92% | -$41K | ﹤0.01% | 1363 |
|
|
2024
Q1 | $158K | Buy |
4,815
+153
| +3% | +$5.01K | ﹤0.01% | 1299 |
|
|
2023
Q4 | $125K | Buy |
4,662
+2,840
| +156% | +$76K | ﹤0.01% | 1334 |
|
|
2023
Q3 | $110K | Buy |
+1,822
| New | +$110K | ﹤0.01% | 1310 |
|
|
2023
Q1 | – | Sell |
-2,821
| Closed | -$1.09M | – | 1477 |
|
|
2022
Q4 | $1.09M | Buy |
2,821
+1,913
| +211% | +$740K | ﹤0.01% | 975 |
|
|
2022
Q3 | $306K | Sell |
908
-409
| -31% | -$138K | ﹤0.01% | 1155 |
|
|
2022
Q2 | $433K | Buy |
+1,317
| New | +$433K | ﹤0.01% | 1206 |
|
|
2021
Q3 | – | Sell |
-20,334
| Closed | -$10.4M | – | 1413 |
|
|
2021
Q2 | $10.4M | Buy |
20,334
+18,559
| +1,046% | +$9.53M | 0.04% | 302 |
|
|
2021
Q1 | $1.39M | Buy |
1,775
+793
| +81% | +$620K | 0.01% | 779 |
|
|
2020
Q4 | $535K | Sell |
982
-3,582
| -78% | -$1.95M | ﹤0.01% | 795 |
|
|
2020
Q3 | $2.09M | Buy |
+4,564
| New | +$2.09M | 0.01% | 541 |
|
|
2020
Q1 | – | Sell |
-1,728
| Closed | -$1M | – | 985 |
|
|
2019
Q4 | $1M | Buy |
+1,728
| New | +$1M | 0.01% | 538 |
|